Inexpensive and stable nature of bovine serum albumin as a protein standard to propel its demand

The Bovine Serum Albumin Market is estimated to be valued at USD 255 million in 2019 and is projected to reach a value of USD 304 million by 2025, growing at a CAGR of 3.0% during the forecast period. Factors such as the inexpensive and stable nature of bovine serum albumin as a protein standard, growing demand for blood-based products are some of the factors driving the growth of the market.

Download PDF Brochure

Most research organizations make use of bovine serum albumin as a protein standard. It is used to determine the unknown quantities of other proteins by comparing the known quantities of bovine serum albumin. For instance, it is used in Bradford protein assay, a method used to measure the concentration of total protein in a sample, as the stable nature of the serum albumin helps in increasing the signal in assays.

Also, bovine serum albumin does not have any effect on many biochemical reactions, which makes scientists in the industry prefer it.It is relatively cheaper than other protein standards due to large quantities of it, which can be easily purified from bovine blood. Some of its other characteristics, which make it a preferred product, include its highly pure nature and its high solubility in water due to which it is finding increased application in the pharmaceutical and diagnostics industries.

The Asia Pacific region holds a range of opportunities for pharmaceutical firms and multinational drugmakers. In the Asia Pacific region, China is the largest market for pharmaceutical products. With the growing interest in health and welfare, the demand for pharmaceutical products is growing. This would help drive the growth of BSA in this region.

The North America region accounted for the largest share in the bovine serum albumin market. The growing livestock sector, the rising demand for red meat & its products, and the increasing rate of cattle slaughtering drive the growth of the bovine serum albumin market in the North American region.

Request for Customization

Key players are Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc (US), Merck KGAA (Germany), Itoham Yonekyu Holdings Inc (Japan), Proliant Biologicals (US), Kraeber & Co Gmbh (Germany), Rockland Immunochemicals Inc (US), Rocky mountain biologicals (US), BelHealth investment partners, LLC (US), Bio-Techne Corporation (US), Prospec-Tany Technogene Ltd (Israel), LGC Group (UK), Promega Corporation (US), Biological Industries (Israel), and Serion GmbH (Germany).

I am a market research analyst in agriculture and food & beverages domain